| 
Thank you for your interest in the commercial
application of Cleveland Clinic technology. Innovations is the Cleveland Clinic's
technology commercialization arm with a mission to
"benefit the sick
through the broad and rapid deployment of Cleveland
Clinic technology." CCI facilitates innovation,
creates spin-off companies, licenses technology, secures
resources and establishes strategic collaborations with
corporate partners.
Cleveland Clinic's long history of innovation
predates to its establishment in 1921.
Recent years have seen Cleveland Clinic
breakthroughs in heart valve repair, minimally invasive
cardiac surgery and the genetics of heart disease. This
year, Cleveland Clinic celebrates its 13th year in a
row ranked as America's #1 heart center in
U.S. News & World Report and is rated as
one of the top three hospitals.
Cleveland Clinic's heritage of innovation
expresses itself in many ways today - more than
200 new inventions per year, new interdisciplinary
approaches to diseases and path-breaking clinical insights
that help shape the standard of care.
Cleveland Clinic has entered a new phase
of technology commercialization. Twenty-four
companies have been spun-off this decade,
most of them with significant equity investment. Clinical
trials conducted at the Clinic have had a dramatic and
growing impact in the venture community. We have had
a record number of licenses.
If you are an investor, entrepreneur, executive
or Cleveland Clinic staff member please
contact us (please see “contact
us” section).
It gives me just a little thrill every time I see a
resurrection here—and there are many—and I realize
that each resuscitation owes its life to a little dingy
dirty laboratory in Cleveland—our laboratory at that.
We assembled it—we ran it—we paid for it and now
many times every day it is all paid back—paid back
in the invisible coin of infinite satisfaction.
George Crile Sr., in a 1917 letter home from the
front lines during World War I. Crile co-founded
Cleveland Clinic after returning from the war.
|
